A modified 4-strata risk assessment incorporating TAPSE/sPAP for pulmonary arterial hypertension: evidence from a large chinese real-world cohort

30 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Risk assessment in pulmonary arterial hypertension Pulmonary Hypertension ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology